Predicting High‐Throughput Screening Results With Scalable Literature‐Based Discovery Methods

The identification of new therapeutic uses for existing agents has been proposed as a means to mitigate the escalating cost of drug development. A common approach to such repurposing involves screening libraries of agents for activities against cell lines. In silico methods using knowledge from the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:CPT: pharmacometrics and systems pharmacology 2014-10, Vol.3 (10), p.1-9
Hauptverfasser: Cohen, T, Widdows, D, Stephan, C, Zinner, R, Kim, J, Rindflesch, T, Davies, P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The identification of new therapeutic uses for existing agents has been proposed as a means to mitigate the escalating cost of drug development. A common approach to such repurposing involves screening libraries of agents for activities against cell lines. In silico methods using knowledge from the biomedical literature have been proposed to constrain the costs of screening by identifying agents that are likely to be effective a priori. However, results obtained with these methods are seldom evaluated empirically. Conversely, screening experiments have been criticized for their inability to reveal the biological basis of their results. In this paper, we evaluate the ability of a scalable literature‐based approach, discovery‐by‐analogy, to identify a small number of active agents within a large library screened for activity against prostate cancer cells. The methods used permit retrieval of the knowledge used to infer their predictions, providing a plausible biological basis for predicted activity. CPT Pharmacometrics Syst. Pharmacol. (2014) 3, e140; doi:10.1038/psp.2014.37; published online 08 October 2014
ISSN:2163-8306
2163-8306
DOI:10.1038/psp.2014.37